Editorial: Cognitive Impairment: Therapy Momentum in the Continuum of Life.
作者信息
Nifli Artemissia-Phoebe, Tsolaki Magda, Tournoy Jos, Ide Kazuki
机构信息
Department of Agriculture Crop Production and Rural Environment, University of Thessaly, Volos, Greece.
Department of Animal Sciences, University of Thessaly, Larissa, Greece.
出版信息
Front Pharmacol. 2021 Jan 29;11:618344. doi: 10.3389/fphar.2020.618344. eCollection 2020.
Abstract
摘要
相似文献
1
Editorial: Cognitive Impairment: Therapy Momentum in the Continuum of Life.社论：认知障碍：生命历程中的治疗动力
Front Pharmacol. 2021 Jan 29;11:618344. doi: 10.3389/fphar.2020.618344. eCollection 2020.
2
Cholinesterase inhibitors for mild cognitive impairment.用于轻度认知障碍的胆碱酯酶抑制剂。
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD009132. doi: 10.1002/14651858.CD009132.pub2.
3
Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis.胆碱酯酶抑制剂治疗血管性痴呆和其他血管性认知障碍：网络荟萃分析。
Cochrane Database Syst Rev. 2021 Feb 22;2(2):CD013306. doi: 10.1002/14651858.CD013306.pub2.
4
Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia.在痴呆症患者中，停用或继续使用胆碱酯酶抑制剂、美金刚或两者。
Cochrane Database Syst Rev. 2021 Feb 3;2(2):CD009081. doi: 10.1002/14651858.CD009081.pub2.
5
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.用于路易体痴呆、帕金森病痴呆及帕金森病认知障碍的胆碱酯酶抑制剂
Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD006504. doi: 10.1002/14651858.CD006504.pub2.
7
8
Cholinesterase inhibitors and memantine for Parkinson's disease dementia and Lewy body dementia: A meta-analysis.用于帕金森病痴呆和路易体痴呆的胆碱酯酶抑制剂和美金刚：一项荟萃分析。
Exp Ther Med. 2019 Mar;17(3):1611-1624. doi: 10.3892/etm.2018.7129. Epub 2018 Dec 24.
9
Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis.胆碱酯酶抑制剂和盐酸美金刚在帕金森病认知障碍、帕金森病痴呆和路易体痴呆中的疗效和安全性：系统评价和荟萃分析及试验序贯分析。
J Neurol Neurosurg Psychiatry. 2015 Feb;86(2):135-43. doi: 10.1136/jnnp-2014-307659. Epub 2014 May 14.
10
Cholinesterase inhibitors for dementia with Lewy bodies.用于路易体痴呆的胆碱酯酶抑制剂。
Cochrane Database Syst Rev. 2003;2003(3):CD003672. doi: 10.1002/14651858.CD003672.
本文引用的文献
1
Serum Concentrations of Cholinesterase Inhibitors in Patients With Alzheimer's Dementia Are Frequently Below the Recommended Levels.阿尔茨海默病痴呆患者血清胆碱酯酶抑制剂浓度常低于推荐水平。
Front Pharmacol. 2020 May 21;11:691. doi: 10.3389/fphar.2020.00691. eCollection 2020.
2
Do Benzodiazepines Cause Alzheimer's Disease?苯二氮䓬类药物会导致阿尔茨海默病吗？
Am J Psychiatry. 2020 Jun 1;177(6):476-478. doi: 10.1176/appi.ajp.2020.20040375.
3
Dementia care during COVID-19.新冠疫情期间的痴呆症护理
Lancet. 2020 Apr 11;395(10231):1190-1191. doi: 10.1016/S0140-6736(20)30755-8. Epub 2020 Mar 30.
4
The search for better animal models of Alzheimer's disease.寻找更好的阿尔茨海默病动物模型。
Nature. 2018 Jul;559(7715):S13-S15. doi: 10.1038/d41586-018-05722-9.
5
Efficacy and Safety of Crocus sativus L. in Patients with Mild Cognitive Impairment: One Year Single-Blind Randomized, with Parallel Groups, Clinical Trial.藏红花对轻度认知障碍患者的疗效和安全性：一年单盲随机平行组临床试验
J Alzheimers Dis. 2016 Jul 27;54(1):129-33. doi: 10.3233/JAD-160304.
6
Implications of GABAergic Neurotransmission in Alzheimer's Disease.γ-氨基丁酸能神经传递在阿尔茨海默病中的意义
Front Aging Neurosci. 2016 Feb 23;8:31. doi: 10.3389/fnagi.2016.00031. eCollection 2016.
Zotero 插件